Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach. Tran JQ, Othman AA, Wolstencroft P, Elkins J Br J Clin Pharmacol. 2016 Mar 17. PMID: 26991517. Abstract CommentRecommendBookmarkWatch